STEINMAN LAWRENCE

CIK 00011326795 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001132679

Recent Transactions

44 trades

Purchase
Pasithea Therapeutics Corp.$KTTA
Common Stock
2025-11-28$0.75/sh+133,333→ 199,691 total
Award
Pasithea Therapeutics Corp.$KTTA
Stock Option (right to buy)
2025-10-24+242,913→ 242,913 total
Award
BioAtla, Inc.$BCAB
Common Stock
2025-06-18+23,500→ 78,459 total
Award
ETHZilla Corp$ETHZ
Common Stock
2025-06-17+44,959→ 112,493 total
Award
ETHZilla Corp$ETHZ
Non-Qualified Stock Option (right to buy)
2025-06-17+110,000→ 110,000 total
Award
ETHZilla Corp$ETHZ
Common Stock
2025-06-17+48,198→ 115,732 total
Award
ETHZilla Corp$ETHZ
Non-Qualified Stock Option (right to buy)
2025-06-17+110,000→ 110,000 total
Award
ETHZilla Corp$ETHZ
Common Stock
2025-02-20+65,000→ 67,534 total
Award
BioAtla, Inc.$BCAB
Common Stock
2024-06-13+16,500→ 54,959 total
Award
Pasithea Therapeutics Corp.$KTTA
Stock Option (right to buy)
2024-03-01+7,500→ 7,500 total
Award
Pasithea Therapeutics Corp.$KTTA
Stock Option (right to buy)
2024-03-01+7,500→ 7,500 total
Purchase
BioAtla, Inc.$BCAB
Common Stock
2023-12-19$2.05/sh+20,000→ 38,459 total
Award
ETHZilla Corp$ETHZ
Non-Qualified Stock Option (right to buy)
2023-09-04+15,000→ 15,000 total
Award
BioAtla, Inc.$BCAB
Stock Option (Right to Buy)
2023-06-14+50,000→ 50,000 total
Purchase
Pasithea Therapeutics Corp.$KTTA
Common Stock
2023-06-02$0.43/sh+30,000→ 1,327,174 total
Purchase
ETHZilla Corp$ETHZ
Common Stock
2023-06-01$1.23/sh+18,000→ 48,129 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-11-28$0.98/sh+5,000→ 1,287,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-11-22$0.99/sh+5,000→ 1,282,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-10-26$1.10/sh+5,000→ 1,277,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-10-17$1.14/sh+1,000→ 1,263,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-10-17$1.13/sh+9,000→ 1,272,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-06-29$1.00/sh+5,000→ 1,272,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-06-28$1.02/sh+5,000→ 1,267,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-06-27$1.00/sh+5,000→ 1,262,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-06-23$1.00/sh+5,000→ 1,257,174 total
Award
Pasithea Therapeutics Corp.$KTTA
Common Stock
2022-06-21+652,174→ 1,252,174 total
Award
BioAtla, Inc.$BCAB
Stock Option (right to buy)
2022-06-16+20,000→ 20,000 total
Purchase
ETHZilla Corp$ETHZ
Common Stock
2021-12-09$4.27/sh+5,000→ 602,574 total
Award
ETHZilla Corp$ETHZ
Stock Option (Right to Buy)
2021-12-08+25,000→ 25,000 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-11-02$30.00/sh−450→ 18,459 total
Award
ETHZilla Corp$ETHZ
Common Stock
2021-09-30$6.00/sh+5,216→ 597,574 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-09-15$36.82/sh−450→ 18,909 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-08-16$40.60/sh−450→ 19,359 total
Award
Pasithea Therapeutics Corp.$KTTA
Stock option (to acquire common stock)
2021-08-02+100,000→ 100,000 total
Sale
BioAtla, Inc.$BCAB
Common Stock
2021-07-15$38.29/sh−450→ 19,809 total
Award
BioAtla, Inc.$BCAB
Stock Option (right to buy)
2021-06-15+12,307→ 12,307 total
Other
BioAtla, Inc.$BCAB
Common Stock
2021-06-14+5,388→ 20,259 total
Award
ETHZilla Corp$ETHZ
Common Stock
2021-04-07$6.14/sh+22,585→ 592,358 total
Conversion
Atreca, Inc.
Class A Common Stock
2019-06-24+8,405→ 258,405 total
Conversion
Atreca, Inc.
Series A Preferred Stock
2019-06-24−8,405→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2005-03-02$41.09/sh−100→ 18,800 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2005-03-02$41.10/sh−2,700→ 16,100 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2005-03-02$41.09/sh−600→ 18,900 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2004-05-26$57.51/sh+12,000→ 12,000 total

STEINMAN LAWRENCE

Recent Transactions

Companies

Recent Filings

Address